Literature DB >> 31862324

Poor results of functional treatment of Garden-1 femoral neck fracture in dependent patients.

Roger Erivan1, Marion Soleihavoup2, Guillaume Villatte3, Daniel Perez Prieto4, Stéphane Descamps3, Stéphane Boisgard3.   

Abstract

INTRODUCTION: Variable results are reported after functional treatment for Garden-1 femoral neck fracture, with no definite factors for failure, particularly in the absence of selection for risk. It seems well indicated in frail and/or dependent patients with comorbidities, but this has not been specifically assessed, and failure is frequent in this target population. We therefore performed a retrospective study to: (1) assess results of functional treatment for Garden-1 impacted femoral neck fracture in dependent patients, and (2) analyze survival in terms of complications and death, and related factors. HYPOTHESIS: Functional treatment for Garden-1 fracture in dependent patients gives poor results, with a high rate of surgical revision.
MATERIAL AND METHODS: A retrospective analysis was made of Garden-1 femoral neck fracture in dependent patients (Parker score≤5), with a minimum 2 years' follow-up. One hundred and forty-six patients were included: mean age, 81.3±8.7 years (range, 55.7-99.6 years). The endpoint was survival in terms of complications requiring surgery, secondary displacement requiring surgery, excessive pain requiring surgery, non-union or femoral head osteonecrosis. Secondary endpoints were overall mortality and mortality related to complications.
RESULTS: Mean follow-up was 4.2±2.6 years (range, 2.0-10.3 years). Ninety-one of the 146 patients (62.3%) required secondary surgery: 79 (54.1%) early (<3 months post-fracture), with 77 (52.7%) secondary displacements and 2 cases (1.4%) of excessive pain; and 12 (8.2%) late (162.2±132.3 days; range, 90-454 days), with 8 (5.4%) non-unions and 4 (2.7%) osteonecroses. Mean time to onset of secondary displacement was 13.6±11.8 days (range, 0-67.0 days). Two-year survival in terms of revision surgery was 34.1% [95% CI: 26.0-42.4]. At last follow-up, 91 patients (62.3%) had died; 2-year survival in terms of death was 69.9% [95% CI: 62.4-77.3]. Survival analysis in terms of complications revealed greater mortality in absence of complications: 42 of the 55 patients (76.3%) without complications requiring surgery died, versus 49 of the 91 (53.8%) with complications requiring surgery (p=0.012); relative risk of death in absence of complications requiring surgery was 1.42 [95% CI: 1.33-5.77]. DISCUSSION: Functional treatment for Garden-1 fracture in dependent patients gave poor short- and medium-term results. Surgery is therefore recommended in this specific population; the present findings should improve survival. LEVEL OF EVIDENCE: IV, retrospective study.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Complications; Dependent patient; Fall; Femoral neck fracture; Functional treatment; Mortality

Mesh:

Year:  2019        PMID: 31862324     DOI: 10.1016/j.otsr.2019.09.027

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  3 in total

1.  Primary total hip replacement in Ficat-Arlet stage 3 and 4 osteonecrosis: a retrospective study at a minimum 12-year follow-up.

Authors:  Roger Erivan; Thomas Caputo; Hicham Riouach; Guillaume Villatte; Bruno Perreira; Stéphane Descamps; Stéphane Boisgard
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-02-27

2.  The proximal femur fracture epidemic continued during the COVID-19 pandemic: Results of an observational study.

Authors:  Solène Prost; Mathieu Carissimi; Andrés Muñoz McCausland; Patrick Tropiano; Jean-Noël Argenson; Benjamin Blondel
Journal:  Orthop Traumatol Surg Res       Date:  2021-11-09       Impact factor: 2.425

3.  [The proximal femur fracture epidemic continued during the COVID-19 pandemic: results of an observational study].

Authors:  Solène Prost; Mathieu Carissimi; Andrés Muñoz McCausland; Patrick Tropiano; Jean-Noël Argenson; Benjamin Blondel
Journal:        Date:  2021-11-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.